Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/42/c5/ef/42c5ef04-9446-c4f7-2955-92d4154e4af4/mza_16556355042048239456.jpg/600x600bb.jpg
Phase Forward
Podcast Series hosted by Valerie Coveney
37 episodes
3 weeks ago
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
Show more...
Health & Fitness
RSS
All content for Phase Forward is the property of Podcast Series hosted by Valerie Coveney and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.
Show more...
Health & Fitness
https://i1.sndcdn.com/artworks-EDFpQlPHXZ1Obpqi-xaAjaA-t3000x3000.jpg
Episode 28: What is New With ICH E6 (R3)?
Phase Forward
20 minutes 3 seconds
6 months ago
Episode 28: What is New With ICH E6 (R3)?
In this episode, Mélanie Pomerleau, Vice President of Quality and Compliance at Indero, joins us to explore the upcoming ICH E6 (R3) guideline revision. With over 25 years in the pharmaceutical and biotech industries, Mélanie shares expert insights on key changes, including the restructured document format, modernized GCP principles, enhanced patient centricity, and the integration of decentralized and adaptive trial designs. We also discuss evolving regulatory expectations, audit trends, and the growing importance of data governance. Tune in to understand how sponsors, CROs, and sites can prepare for the July 2025 implementation and navigate this transition.
Phase Forward
This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.